73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Tracking the epigenetic evolution of a cancer, cell by cell

Tracking the epigenetic evolution of a cancer, cell by cell

by Weill Cornell Medical CollegeDr. Dan Landau. Credit: Rene PerezA powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables

Tracking the epigenetic evolution of a cancer, cell by cell

by Weill Cornell Medical CollegeDr. Dan Landau. Credit: Rene PerezA powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables
Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

by Impact Journals LLCEverolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.283

Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

by Impact Journals LLCEverolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.283
Drug compound could be next-generation treatment for aggressive form of leukemia

Drug compound could be next-generation treatment for aggressive form of leukemia

by Tom Coyne,Purdue UniversityHerman Sintim, the Drug Discovery Professor of Chemistry in Purdue University's Department of Chemistry, is leading a team of researchers developing a series of

Drug compound could be next-generation treatment for aggressive form of leukemia

by Tom Coyne,Purdue UniversityHerman Sintim, the Drug Discovery Professor of Chemistry in Purdue University's Department of Chemistry, is leading a team of researchers developing a series of
Poor oral health linked to a 75% increase in liver cancer risk, new study finds

Poor oral health linked to a 75% increase in liver cancer risk, new study finds

by SAGE PublicationsCredit: CC0 Public DomainThe study, by researchers at Queen's University Belfast, analysed a large cohort of over 469,000 people in the UK, investigated the association be

Poor oral health linked to a 75% increase in liver cancer risk, new study finds

by SAGE PublicationsCredit: CC0 Public DomainThe study, by researchers at Queen's University Belfast, analysed a large cohort of over 469,000 people in the UK, investigated the association be
Combination therapy overcomes BET inhibitor resistance, shows study

Combination therapy overcomes BET inhibitor resistance, shows study

bySt. Jude Children's Research HospitalStudy first author Shaela Fields (Wright), from the lab of Chunliang, Li, PhD, St. Jude Department of Tumor Cell Biology, led research to understand BE

Combination therapy overcomes BET inhibitor resistance, shows study

bySt. Jude Children's Research HospitalStudy first author Shaela Fields (Wright), from the lab of Chunliang, Li, PhD, St. Jude Department of Tumor Cell Biology, led research to understand BE
New biomarker for early prediction of response to CAR-T cell therapy

New biomarker for early prediction of response to CAR-T cell therapy

by Medical University of ViennaCredit: AI-generated imageA MedUni Vienna research team has discovered a highly potent biomarker for clinical response to CAR-T cell therapy, describing the prerequ

New biomarker for early prediction of response to CAR-T cell therapy

by Medical University of ViennaCredit: AI-generated imageA MedUni Vienna research team has discovered a highly potent biomarker for clinical response to CAR-T cell therapy, describing the prerequ
First-of-its-kind tool to check potential inherited risk of pancreatic cancer launches

First-of-its-kind tool to check potential inherited risk of pancreatic cancer launches

byUniversity of LiverpoolCredit: Unsplash/CC0 Public DomainFamilies who have been affected by pancreatic cancer can assess their risk of inheriting the disease through a new first-of-its-kind&nb

First-of-its-kind tool to check potential inherited risk of pancreatic cancer launches

byUniversity of LiverpoolCredit: Unsplash/CC0 Public DomainFamilies who have been affected by pancreatic cancer can assess their risk of inheriting the disease through a new first-of-its-kind&nb
Chemotherapy-resistant ovarian cancer cells protect their neighbors, shows study

Chemotherapy-resistant ovarian cancer cells protect their neighbors, shows study

by University of PittsburghCredit: Unsplash/CC0 Public DomainCertain chemotherapy-resistant ovarian cancer cells protect neighboring cancer cells by sending signals that induce resistance, accord

Chemotherapy-resistant ovarian cancer cells protect their neighbors, shows study

by University of PittsburghCredit: Unsplash/CC0 Public DomainCertain chemotherapy-resistant ovarian cancer cells protect neighboring cancer cells by sending signals that induce resistance, accord
Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

by Allie Miller,University of CalgaryResidential radon exposure periods modified by radon awareness behavior and test decision-making that can differ by age, sex/gender or parental status. Credi

Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

by Allie Miller,University of CalgaryResidential radon exposure periods modified by radon awareness behavior and test decision-making that can differ by age, sex/gender or parental status. Credi
Newly identified personalized immunotherapy combination treats an aggressive form of advanced prostate cancer

Newly identified personalized immunotherapy combination treats an aggressive form of advanced prostate cancer

byUniversity of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainImmunotherapies have been successful in treating many cancer conditions; however, not much success has yet been achieved i

Newly identified personalized immunotherapy combination treats an aggressive form of advanced prostate cancer

byUniversity of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainImmunotherapies have been successful in treating many cancer conditions; however, not much success has yet been achieved i
Research finds unexpected link between chromosomal instability and epigenetic alterations

Research finds unexpected link between chromosomal instability and epigenetic alterations

by Ian Demsky,Memorial Sloan Kettering Cancer CenterThe two colored dots outside of this breast cancer cell's primary nucleus indicate the presence of micronuclei. A new study investigated h

Research finds unexpected link between chromosomal instability and epigenetic alterations

by Ian Demsky,Memorial Sloan Kettering Cancer CenterThe two colored dots outside of this breast cancer cell's primary nucleus indicate the presence of micronuclei. A new study investigated h
Researchers identify targeted therapy that can help children with deadly nerve cancer

Researchers identify targeted therapy that can help children with deadly nerve cancer

by The Mount Sinai HospitalCredit: CC0 Public DomainMount Sinai researchers have identified a targeted therapy for adolescent patients with neuroblastoma, a deadly pediatric nerve cancer, who wou

Researchers identify targeted therapy that can help children with deadly nerve cancer

by The Mount Sinai HospitalCredit: CC0 Public DomainMount Sinai researchers have identified a targeted therapy for adolescent patients with neuroblastoma, a deadly pediatric nerve cancer, who wou